Stockscreener 앱 받기
13.02
3.42%
0.43
전일 마감가:
$12.59
열려 있는:
$12.5
하루 거래량:
8.35M
Relative Volume:
3.22
시가총액:
$1.36B
수익:
$64.52M
순이익/손실:
$-95.55M
주가수익비율:
-12.80
EPS:
-1.0169
순현금흐름:
$-84.65M
1주 성능:
+23.53%
1개월 성능:
+45.64%
6개월 성능:
+59.95%
1년 성능:
+104.40%
1일 변동 폭
$12.26
$13.37
1주일 범위
$9.65
$13.37
52주 변동 폭
$3.84
$13.37
Personalis Inc Stock (PSNL) Company Profile
명칭
Personalis Inc
전화
650-752-1300
주소
6600 DUMBARTON CIRCLE, FREMONT, CA
Compare PSNL vs TMO, DHR, IDXX, A, NTRA
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PSNL
Personalis Inc
|
13.02 | 1.32B | 64.52M | -95.55M | -84.65M | -1.0169 |
TMO
Thermo Fisher Scientific Inc
|
513.03 | 187.95B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
196.19 | 136.75B | 24.78B | 3.68B | 5.29B | 5.1743 |
IDXX
Idexx Laboratories Inc
|
551.50 | 43.78B | 4.45B | 1.10B | 1.06B | 13.59 |
A
Agilent Technologies Inc
|
136.01 | 38.27B | 7.23B | 1.41B | 1.09B | 4.979 |
NTRA
Natera Inc
|
261.91 | 37.34B | 2.50B | -226.32M | 71.51M | -1.6412 |
Personalis Inc Stock (PSNL) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-02 | 재개 | Morgan Stanley | Equal-Weight |
| 2025-05-15 | 개시 | Guggenheim | Buy |
| 2025-03-17 | 개시 | Craig Hallum | Buy |
| 2023-02-06 | 업그레이드 | Needham | Hold → Buy |
| 2022-01-07 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2021-11-05 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2021-11-03 | 다운그레이드 | Needham | Buy → Hold |
| 2021-10-15 | 재개 | Cowen | Outperform |
| 2021-09-20 | 재확인 | Needham | Buy |
| 2021-05-06 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2021-01-28 | 개시 | Truist | Buy |
| 2021-01-04 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2020-11-12 | 재확인 | Needham | Buy |
| 2020-11-06 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2020-10-19 | 개시 | Citigroup | Buy |
| 2020-10-08 | 개시 | BTIG Research | Buy |
| 2020-08-27 | 개시 | H.C. Wainwright | Buy |
| 2020-08-18 | 개시 | Needham | Buy |
| 2019-09-26 | 업그레이드 | BofA/Merrill | Neutral → Buy |
| 2019-07-15 | 개시 | BofA/Merrill | Neutral |
| 2019-07-15 | 개시 | Cowen | Outperform |
| 2019-07-15 | 개시 | Morgan Stanley | Overweight |
| 2019-07-15 | 개시 | Oppenheimer | Outperform |
모두보기
Personalis Inc 주식(PSNL)의 최신 뉴스
Personalis CEO Christopher Hall sells $1.31m in company stock By Investing.com - Investing.com Australia
Personalis CFO Aaron Tachibana sells $675,488 in company stock - Investing.com
Form 4 Personalis Inc For: 26 June By Investing.com - Investing.com UK
Personalis (PSNL) CFO uses 10b5-1 plan to exercise options and sell shares - Stock Titan
Personalis (PSNL) CEO sells 100K shares after exercising options - Stock Titan
Form 144 Personalis For: 26 June By Investing.com - Investing.com Canada
PSNL: Form 144 lists 51,251 shares to be sold; prior 10b5-1 sales noted - Stock Titan
Broker files Form 144 as Christopher Hall sells 100,000 PSNL shares (PSNL) - Stock Titan
Personalis, Inc. Actuals & Estimates (NASDAQ:PSNL) - TradingView
PSNL Forecast — Price Target — Prediction for 2027 - TradingView
Price to book forward of Personalis, Inc. – NASDAQ:PSNL - TradingView
Personalis stock hits 52-week high at 12.53 USD By Investing.com - Investing.com South Africa
Personalis stock hits 52-week high at 12.53 USD - Investing.com
Personalis Inc (PSNL) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Why Personalis Stock Is Rising: Medicare Covers Lung Cancer MRD Test - Stocktwits
Personalis Inc (PSNL) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Numerous Personalis Insiders Sold Stock: Not A Positive Omen - 富途牛牛
Q1 2026 Personalis Inc Earnings Call Transcript - GuruFocus
Personalis Inc (PSNL) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Personalis Inc (PSNL) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Personalis Inc (PSNL) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Personalis Inc (PSNL) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Personalis Inc (PSNL) Institutional Confidence - TradingKey
Personalis Inc (PSNL) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Personalis Inc (PSNL) Valuation: PE, PB & Fair Value Analysis - TradingKey
PSNL Q1 2026 Earnings: EPS Misses Estimates, Stock Declines on Weak ResultsRetail Earnings Report - newsline.com
Personalis (NASDAQ: PSNL) director receives 6,250 RSU award in Form 4/A update - Stock Titan
Lightspeed funds (NASDAQ: PSNL) report 5.8% Personalis stake after in-kind distributions - Stock Titan
Personalis Inc. (PSNL) Q1 2026 Earnings: Loss Wider Than Expected, Stock DipsPost-Announcement Reaction - newsline.com
Personalis blood collection kits receive EU regulatory approval - Investing.com UK
Personalis (PSNL) Receives CE Mark Approval for Blood Collection Kits - GuruFocus
Personalis Gains EU Approval for Blood Collection Kits Used in Genomic Testing - Moomoo
Personalis blood collection kits receive EU regulatory approval By Investing.com - Investing.com Nigeria
Personalis Enables Global Biopharma Support with CE-IVD Marked Specimen Collection Kits - Business Wire
Personalis, Inc. Hits Day Low of $10.39 Amid Price Pressure - MarketsMojo
Personalis, Inc. Hits New 52-Week High of $11.84, Up 763.64% - MarketsMojo
Personalis CFO Aaron Tachibana sells $480,400 in company stock By Investing.com - Investing.com India
Personalis CFO Aaron Tachibana sells $480,400 in company stock - Investing.com UK
Personalis (NASDAQ: PSNL) CFO sells 40,000 shares under 10b5-1 plan - Stock Titan
Personalis Inc. (PSNL) Q1 2026 Earnings: EPS Misses Estimates Amid Revenue Reporting GapsNegative Surprise Momentum - newsline.com
Aaron L. Tachibana (PSNL) exercises 40,000 options; prior 38,799 10b5-1 sale - Stock Titan
Personalis CEO Sells 100,000 Company Shares Worth $1.1 Million. What Does That Mean for Investors? - The Globe and Mail
Personalis Inc. (PSNL) Q1 2026 Earnings: EPS Misses Estimates as Stock DeclinesEPS Estimate Trend - newsline.com
Personalis Data Highlights Early Cancer Recurrence Detection - Clinical Lab Products
Personalis Highlights Early Colorectal Cancer Recurrence Detection and Ultrasensitive MRD Performance Across a Broad Set of Tumor Types at ASCO 2026 - BioSpace
Assessing Personalis (PSNL) Valuation After Its Strong Recent Share Price Momentum - Yahoo Finance
Personalis Insider Sold Shares Worth $449,292, According to a Recent SEC Filing - marketscreener.com
Personalis CFO and COO Aaron Tachibana sells $449,292 in stock By Investing.com - Investing.com South Africa
Personalis CEO Christopher M. Hall sells $1.1m in stock By Investing.com - Investing.com India
Personalis Inc (PSNL) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.76%
0.62%
자본화:
|
볼륨(24시간):